Development of a non-human primate model for the identification and development of novel therapeutics for dystonia

Ended Project Grant Awarded Last action

Award ID
W81XWH2211043
Recipient
Awarding agency
Obligated
$1,528,921

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from USAspending.gov.

About this award

Atuka Inc. will receive $1,528,921 under a four-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will support Atuka's development of a non-human primate model for identifying and developing novel therapeutics for dystonia. Through this research, Atuka aims to transform healthcare for service members and the public by investigating medical solutions for conditions impacting the battlefield. The Military Medical Research and Development program seeks to advance biomedical research that supports the health of those in military service. Atuka will conduct the research at its facility in Ottawa, Canada from September 2022 through September 2026 to pursue this important medical mission.

Quick answers

Who received award W81XWH2211043?

W81XWH2211043 was awarded to Atuka Inc. by Medical Command (Department of the Army) on September 30, 2022.

How much is award W81XWH2211043 worth?

$1,528,921 has been obligated on W81XWH2211043.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award